BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8488716)

  • 1. Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits.
    Nisini R; Biselli R; Matricardi PM; Fattorossi A; D'Amelio R
    Vaccine; 1993; 11(5):582-6. PubMed ID: 8488716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines.
    D'Amelio R; Tagliabue A; Nencioni L; Di Addario A; Villa L; Manganaro M; Boraschi D; Le Moli S; Nisini R; Matricardi PM
    Infect Immun; 1988 Oct; 56(10):2731-5. PubMed ID: 3417354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of active component US military personnel against Salmonella Typhi.
    Porter CK; Sorrell T; Mitra I; Riddle MS
    Vaccine; 2017 Mar; 35(14):1742-1748. PubMed ID: 28268075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a as measured using peripheral blood lymphocytes.
    Forrest BD; LaBrooy JT
    Vaccine; 1993; 11(2):136-9. PubMed ID: 8438612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typhim Vi vaccine against typhoid fever: a clinical trial in Kenya.
    Mirza NB; Wamola IA; Estambale BA; Mbithi E; Poillet M
    East Afr Med J; 1995 Mar; 72(3):162-4. PubMed ID: 7796767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
    Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
    Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity.
    Beran J; Beutels M; Levie K; Van Damme P; Dieussaert I; Gillet M; Van Hoecke C; Tornieporth N
    J Travel Med; 2000; 7(5):246-52. PubMed ID: 11231208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of oral typhoid vaccination on the human gut microbiota and correlations with s. Typhi-specific immunological responses.
    Eloe-Fadrosh EA; McArthur MA; Seekatz AM; Drabek EF; Rasko DA; Sztein MB; Fraser CM
    PLoS One; 2013; 8(4):e62026. PubMed ID: 23637957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
    Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN
    J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a.
    Forrest BD; LaBrooy JT; Dearlove CE; Shearman DJ
    Infect Immun; 1992 Feb; 60(2):465-71. PubMed ID: 1730477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.
    Tacket CO; Levine MM; Robbins JB
    Vaccine; 1988 Aug; 6(4):307-8. PubMed ID: 3188615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Typhoid Vaccination With Live-Attenuated Salmonella Typhi Strain Ty21a Generates Ty21a-Responsive and Heterologous Influenza Virus-Responsive CD4+ and CD8+ T Cells at the Human Intestinal Mucosa.
    Pennington SH; Thompson AL; Wright AK; Ferreira DM; Jambo KC; Wright AD; Faragher B; Gilmour JW; Gordon SB; Gordon MA
    J Infect Dis; 2016 Jun; 213(11):1809-19. PubMed ID: 26810369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.
    Frey SE; Lottenbach KR; Hill H; Blevins TP; Yu Y; Zhang Y; Brenneman KE; Kelly-Aehle SM; McDonald C; Jansen A; Curtiss R
    Vaccine; 2013 Oct; 31(42):4874-80. PubMed ID: 23916987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.
    Zhou WZ; Koo HW; Wang XY; Zhang J; Park JK; Zhu F; Deen J; Acosta CJ; Chen Y; Wang H; Galindo CM; Ochiai L; Park T; von Seidlein L; Xu ZY; Clemens JD
    Pediatr Infect Dis J; 2007 Nov; 26(11):1001-5. PubMed ID: 17984806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.
    Hohmann EL; Oletta CA; Killeen KP; Miller SI
    J Infect Dis; 1996 Jun; 173(6):1408-14. PubMed ID: 8648213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.
    Klugman KP; Gilbertson IT; Koornhof HJ; Robbins JB; Schneerson R; Schulz D; Cadoz M; Armand J
    Lancet; 1987 Nov; 2(8569):1165-9. PubMed ID: 2890805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.